Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hanmi Pharmaceutical
Biotech
Aptose to pay Hanmi up to $420M for myeloid inhibitor
Hanmi Pharmaceutical's early-stage acute myeloid leukemia drug gives Aptose Biosciences the confidence to sign a $420 million licensing pact.
Kyle LaHucik
Nov 4, 2021 10:37am
Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues
Jun 28, 2021 5:19pm
Merck bags J&J castoff from Hanmi to expand NASH pipeline
Aug 4, 2020 6:51am
Sanofi culls pipeline dud, still looking to out-license meds
Apr 24, 2020 8:10am
Rapt edges into Asia with Hanmi I-O deal worth up to $118M
Dec 3, 2019 4:05pm
J&J dumps Hanmi obesity drug following midphase trials
Jul 8, 2019 10:31am
